Cargando...
Discordance in investigator-reported and adjudicated sudden death in TIOSPIR
Accurate and consistent determination of cause of death is challenging in chronic obstructive pulmonary disease (COPD) patients. TIOSPIR (N=17 135) compared the safety and efficacy of tiotropium Respimat 5/2.5 µg with HandiHaler 18 µg in COPD patients. All-cause mortality was a primary end-point. A...
Gardado en:
| Publicado en: | ERJ Open Res |
|---|---|
| Main Authors: | , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
European Respiratory Society
2017
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5358526/ https://ncbi.nlm.nih.gov/pubmed/28344980 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1183/23120541.00073-2016 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|